SK161199A3 - Cyanoguanidines as cell proliferation inhibitors - Google Patents

Cyanoguanidines as cell proliferation inhibitors Download PDF

Info

Publication number
SK161199A3
SK161199A3 SK1611-99A SK161199A SK161199A3 SK 161199 A3 SK161199 A3 SK 161199A3 SK 161199 A SK161199 A SK 161199A SK 161199 A3 SK161199 A3 SK 161199A3
Authority
SK
Slovakia
Prior art keywords
compound
cyano
formula
acid
alkyl
Prior art date
Application number
SK1611-99A
Other languages
English (en)
Slovak (sk)
Inventor
Erik Rytter Ottosen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of SK161199A3 publication Critical patent/SK161199A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK1611-99A 1997-05-29 1998-05-15 Cyanoguanidines as cell proliferation inhibitors SK161199A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9711119.9A GB9711119D0 (en) 1997-05-29 1997-05-29 Novel cyanoguanidines
PCT/DK1998/000195 WO1998054143A1 (en) 1997-05-29 1998-05-15 Cyanoguanidines as cell proliferation inhibitors

Publications (1)

Publication Number Publication Date
SK161199A3 true SK161199A3 (en) 2000-06-12

Family

ID=10813249

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1611-99A SK161199A3 (en) 1997-05-29 1998-05-15 Cyanoguanidines as cell proliferation inhibitors

Country Status (19)

Country Link
US (1) US6121297A (is)
EP (1) EP0984937A1 (is)
JP (1) JP2001526693A (is)
KR (1) KR20010013158A (is)
CN (1) CN1314890A (is)
AU (1) AU733093B2 (is)
BG (1) BG103867A (is)
BR (1) BR9809496A (is)
CA (1) CA2291489A1 (is)
EA (1) EA002037B1 (is)
EE (1) EE03871B1 (is)
GB (1) GB9711119D0 (is)
HK (1) HK1039116A1 (is)
HU (1) HUP0003150A3 (is)
IS (1) IS5229A (is)
NZ (1) NZ500702A (is)
PL (1) PL337091A1 (is)
SK (1) SK161199A3 (is)
WO (1) WO1998054143A1 (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000061561A1 (en) 1999-04-09 2000-10-19 Shionogi Bioresearch Corp. Cyanoguanidine compounds
AU1494702A (en) 2000-11-21 2002-06-03 Leo Pharma As Cyanoguanidine prodrugs
US20030045515A1 (en) * 2001-05-24 2003-03-06 Lise Binderup Combination medicament for treatment of neoplastic diseases
WO2002094265A1 (en) * 2001-05-24 2002-11-28 Leo Pharma A/S A method of modulating nf-$g(k)b activity
US6642215B2 (en) * 2001-05-24 2003-11-04 Leo Pharma A/S Method of modulating NF-kB activity
PL366459A1 (en) 2001-05-24 2005-02-07 Leo Pharma A/S Novel pyridyl cyanoguanidine compounds
US7253193B2 (en) 2002-05-17 2007-08-07 Leo Pharma A/S Cyanoguanidine prodrugs
WO2006066584A1 (en) 2004-12-22 2006-06-29 Leo Pharma A/S Novel cyanoguanidine compounds
US8211912B2 (en) 2007-09-26 2012-07-03 Gemin X Pharmaceuticals Canada Compositions and methods for effecting NAD+ levels using a nicotinamide phosphoribosyl tranferase inhibitor
US8173677B2 (en) 2007-09-26 2012-05-08 Gemin X Pharmaceuticals Canada Inc. Compositions and methods for effecting NAD+ levels using a nicotinamide phosphoribosyl transferase inhibitor
CA2751495C (en) 2009-02-06 2013-08-20 Tianjin Hemay Bio-Tech Co., Ltd. Pharmaceutical compositions comprising a pyridyl cyanoguanidine and cyclodextrin and/or derivatives thereof
KR20140020823A (ko) 2010-09-03 2014-02-19 포르마 티엠, 엘엘씨. Nampt의 억제를 위한 구아니딘 화합물 및 조성물
JP2013540781A (ja) 2010-10-26 2013-11-07 ティエンジン ホーメイ バイオ−テック カンパニー, リミテッド N−(6−(4−クロロフェノキシ)ヘキシル)−n’−シアノ−n’’−(4−ピリジル)グアニジンの結晶多形とその製造及び使用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9219472D0 (en) * 1992-09-15 1992-10-28 Leo Pharm Prod Ltd Chemical compounds

Also Published As

Publication number Publication date
HUP0003150A3 (en) 2002-10-28
IS5229A (is) 1999-10-26
JP2001526693A (ja) 2001-12-18
GB9711119D0 (en) 1997-07-23
AU7638598A (en) 1998-12-30
PL337091A1 (en) 2000-07-31
BR9809496A (pt) 2000-06-20
US6121297A (en) 2000-09-19
EE9900551A (et) 2000-06-15
HK1039116A1 (zh) 2002-04-12
EA199901096A1 (ru) 2000-08-28
BG103867A (en) 2001-05-31
HUP0003150A2 (en) 2001-03-28
EA002037B1 (ru) 2001-12-24
EE03871B1 (et) 2002-10-15
CN1314890A (zh) 2001-09-26
NZ500702A (en) 2001-07-27
CA2291489A1 (en) 1998-12-03
KR20010013158A (ko) 2001-02-26
AU733093B2 (en) 2001-05-03
WO1998054143A1 (en) 1998-12-03
EP0984937A1 (en) 2000-03-15

Similar Documents

Publication Publication Date Title
JP4408455B2 (ja) 細胞増殖抑制剤としてのシアノグアニジン
RU2195452C2 (ru) Цианогуанидины, способы их получения и фармацевтический препарат на их основе
SK161199A3 (en) Cyanoguanidines as cell proliferation inhibitors
RU2194697C2 (ru) Цианогуанидины, способы их получения и фармацевтический препарат на их основе
US6300345B1 (en) Cyanoguanidines as cell proliferation inhibitors
WO1998054142A1 (en) Cyanoguanidines as cell proliferation inhibitors
CZ419199A3 (cs) Kyanoguanidiny jako inhibitory buněčné proliferace
US6303641B1 (en) Cyanoamidines as cell proliferation inhibitors
CZ9904237A3 (cs) Kyanoguanidiny jako inhibitory buněčné proliferace
CZ9904238A3 (cs) Kyanoguanidiny jako inhibitory buněčné proliferace
CZ9904239A3 (cs) Kyanoamidiny jako inhibitory buněčné proliferace